NeuBase Therapeutics (NBSE) Q2 2023 Earnings

Aug 14Confirmed
Dec 2022
Q4 2022
Q1 2023
Q2 2023
-2.04
-1.4
-0.75
-0.11

Details

Expected EPS
N/A
Actual EPS
-2.04
Surprise EPS
N/A
Surprise Percent
N/A

Description

⁨NeuBase Therapeutics⁩ (⁦NBSE⁩) has reported earnings of ⁦-2.04⁩ per share for ⁦Q2 2023⁩.

0 Comments

Share your thoughts